BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Ischemia
,
Hypothalamus
,
Nosology
,
Doxycycline
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
AKR1C1;jsessionid=3D0C496B53042FAB1F84C88747348A42
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal liver
Adipose tissue subcutaneous
Liver
Bronchus
Bladder
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma.
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferrop…
Closed Reduction, Arthrogram and Spica Application for DDH.
AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent…
Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for AKR1C1;jsessionid=3D0C496B53042FAB1F84C88747348A42
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ